FDA Device recall Z-1622-2013
MAQUET Getinge Group Mobile Operating Table YUNO OTN GA 1433.01 EN 05
- FDA Device
- Class II
- terminated
- Published 2013-07-10
On 2013-07-10 the FDA classified a Class II recall of MAQUET Getinge Group Mobile Operating Table YUNO OTN GA 1433.01 EN 05 by Maquet Cardiovascular Us Sales, citing MAQUET has identified a potential issue with the extension device handle (part number 1433.62A1) and will make enhancements to the YUNO table (part number 1433.01F0). Identificati….
Read the official FDA Device notice
| Agency | FDA Device |
|---|---|
| Recall number | Z-1622-2013 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2013-04-26 |
| Published | 2013-07-10 |
| Last updated | 2026-09-13 11:53 UTC |
| Company | Maquet Cardiovascular Us Sales |
| Distribution | AZ, GA, ND, SC, TN, TX |
Product
MAQUET Getinge Group Mobile Operating Table YUNO OTN GA 1433.01 EN 05. The YUNO OTN is used to support and position patients for surgical procedures immediately before, during and after the surgical phase. The table top is radio translucent and enables intraoperative use of X-ray equipment.
Reason
MAQUET has identified a potential issue with the extension device handle (part number 1433.62A1) and will make enhancements to the YUNO table (part number 1433.01F0). Identification of the Extension device issue: By fully actuating the lever of the extension device handle, the operator's skin can enter a gap between the handle lever and a recess in the handle bar. When the lever is released,
Identifiers
| code_info | YUNO OTN Mobile Operating Table: 1433.01F0 Extension Device: 1433.62A1 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:53 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-1622-2013%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.